Zota Health Care Announces FY2026 Results and Strategic Investment in Davaindia Health Mart
Zota Health Care Limited announced key outcomes from its Board meeting held on May 22, 2026. The Board considered and approved the Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31, 2026, along with the corresponding audit reports.The Company recommended a final dividend of 10%, equivalent to Re. 1/- per equity share of Rs. 10/- each, for the financial year 2025-26, which is subject to the approval of the shareholders at the Annual General Meeting.
Financial Performance Overview
The audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, reflected the Company's operational and financial activities. The audit reports were issued by Pradeep K. Singhi & Associates, Chartered Accountants, who provided an Unmodified opinion.A comparison of the audited financial results for the quarter and year ended March 31, 2026, are presented below:
Audited Standalone Financial Results (Lakhs)
| Particulars | Quarter Ended 31-Mar-26 (Audited) | Year Ended 31-Mar-26 (Audited) |
|---|---|---|
| Revenue from Operations | 12070.05 | 40700.72 |
| Other income | 410.33 | 1340.18 |
| Total Income | 12480.38 | 42040.91 |
| Total Expenses | 11669.23 | 37965.54 |
| Profit/(Loss) for the period from Continuing Operations | 608.87 | 2790.66 |
| Profit/(Loss) for the period | 608.87 | 2790.66 |
| Total comprehensive Income for the period | 632.09 | 2828.68 |
Audited Consolidated Financial Results (Lakhs)
| Particulars | Quarter Ended 31-Mar-26 (Audited) | Year Ended 31-Mar-26 (Audited) |
|---|---|---|
| Revenue from Operations | 16317.53 | 53865.75 |
| Other Income | 320.80 | 743.75 |
| Total Income | 15631.33 | 54609.50 |
| Total Expenses | 11610.53 | 61993.19 |
| Profit/(Loss) for the period from Continuing Operations | (1446.19) | (7407.74) |
| Profit/(Loss) for the period | (1446.19) | (7407.74) |
| Total comprehensive Income for the period | (1361.83) | (7254.56) |
Strategic Investment and Acquisition
The Board meeting also approved the acquisition of 39,794 equity shares of M/s Davaindia Health Mart Limited, a Wholly Owned Subsidiary of the Company, through a right issue subscription.The details of this acquisition are summarized in the following table:
Investment Details (Davaindia Health Mart Limited)
| Parameter | Detail |
|---|---|
| Shares Acquired | 39,794 equity shares |
| Transaction Mechanism | Subscription to the right issue |
| Cost of Acquisition (Total) | Rs. 20,19,54,550/- |
| Cost per Share (Including Premium) | Rs. 5,075/- |
| Post-acquisition Status | DIHML remains a WOS of the Company |
The acquisition represents a strategic investment aimed at the expansion of the COCO (Company Owned Company Operated) stores of Davaindia.
Financial Statements Summary
The financial health of Zota Health Care Limited was detailed across various financial statements for the periods ended March 31, 2026, and March 31, 2025.Standalone and Consolidated Balance Sheet (Amounts in Lakhs)
| Particulars | As at March 31, 2026 (Audited) | As at March 31, 2025 (Audited) |
|---|---|---|
| Total Assets | 111305.14 | 43914.05 |
| Total Equity | 69616.56 | 22715.48 |
| Total Liabilities | 41688.58 | 21198.57 |
Cash Flow from Operating Activities (Amounts in Lakhs)
| Particulars | FY Ended March 31, 2026 | FY Ended March 31, 2025 |
|---|---|---|
| Net Profit Before Tax | (7383.69) | (5764.43) |
| Operating Profit before Working Capital Changes | 1397.99 | (649.65) |
| Net Cash Flow from Operating Activities | (18442.54) | (4996.43) |
| Net Cash Flow from Financing Activities | 48994.29 | 14476.35 |
| Closing Balance of Cash and Cash Equivalents | 9557.41 | 361.91 |
For detailed figures, the full standalone and consolidated audited statements, including Cash Flow and Balance Sheet details, were provided.
ZOTA Stock Price Movement
On Friday, Zota Health Care Limited shares slipped by 2.16% to close at ₹1192.6, marking a significant drop from previous levels. The stock found purchase amidst trading activity that saw a volume of 26,128 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: